# Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

> **NCT00536497** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** GW842166X

## Key facts

- **NCT ID:** NCT00536497
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Compound terminated
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536497, "Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00536497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*